OLMA - Olema Pharmaceuticals, Inc. -  [ ]

Ticker Details
Olema Pharmaceuticals, Inc.
IPO Date: November 16, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.19B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.52 | 3.90%
Avg Daily Range (30 D): $0.30 | 2.00%
Avg Daily Range (90 D): $0.54 | 2.87%
Institutional Daily Volume
Avg Daily Volume: .65M
Avg Daily Volume (30 D): .78M
Avg Daily Volume (90 D): 1.16M
Trade Size
Avg Trade Size (Sh.): 85
Avg Trade Size (Sh.) (30 D): 55
Avg Trade Size (Sh.) (90 D): 67
Institutional Trades
Total Institutional Trades: 1,203
Avg Institutional Trade: $1.98M
Avg Institutional Trade (30 D): $2.03M
Avg Institutional Trade (90 D): $2.51M
Avg Institutional Trade Volume: .14M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.63M
Avg Closing Trade (30 D): $2.24M
Avg Closing Trade (90 D): $3.45M
Avg Closing Volume: 176.05K
 
News
May 21, 2026 @ 9:00 PM
Olema Oncology Announces Encouraging Initial Clini...
Source: Olema Oncology
May 20, 2026 @ 5:00 PM
ESR1-Mutated Metastatic Breast Cancer Market Expec...
Source: Delveinsight
Mar 16, 2026 @ 11:00 AM
Olema Oncology Reports Fourth Quarter and Full Yea...
Source: Na
Mar 9, 2026 @ 5:57 PM
Olema Pharmaceuticals, Inc. Investigated on Behalf...
Source: Business Wire
Jan 9, 2026 @ 4:08 PM
Olema Insider Sells $8 Million in Shares After 300...
Source: Jonathan Ponciano
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-2.03 $-.52 $-.51
Diluted EPS $-2.03 $-.52 $-.51
Revenue $M $M $M
Gross Profit
Net Income / Loss $-185.15M $-53.09M $-46.06M
Operating Income / Loss $-201.81M $-57.99M $-50.08M
Cost of Revenue
Net Cash Flow $1.91M $4.25M $13.04M
PE Ratio